Cardio Partners, Inc.

Cardio Partners, Inc., doing business as DXE Medical, supplies automated external defibrillators (AEDs), replacement components, CPR training manikins, and related cardiac emergency preparedness equipment to federal agencies as a prime contractor on a GSA Federal Supply Schedule vehicle, competing full-and-open with no set-aside designations across 289 prime awards (99% of recent activity).

Cardio Partners is a foreign-owned, for-profit organization headquartered in Dublin, Ohio. The vendor operates primarily under NAICS 334510 (Surgical and Medical Instrument Manufacturing) and PSC 6515 (Medical and Surgical Instruments, Equipment, and Supplies), with secondary exposure under NAICS 423450 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers). The company does not hold SBA set-asides and competes in unrestricted federal procurements.

The vendor's federal footprint centers on a $15.8 million GSA Federal Supply Schedule contract under Medical Equipment and Supplies (FSS-65-II-A), awarded September 1, 2023, running through August 31, 2028. This multiple-award vehicle accounts for 207 task orders valued at $16.8 million in combined potential value and serves as the contracting mechanism for the vast majority of Cardio Partners' federal work. Representative prime awards include a $3.146 million time-and-materials delivery order with the U.S. Marshals Service (awarded September 2023) for AED equipment, training, and management services through September 2026; a $42.367 million delivery order with the Mine Safety and Health Administration (November 2024) for the AED Program through December 2029; a $40.746 million delivery order with the Department of Health and Human Services (March 2024) for casualty care training manikins; a $22.044 million order from the U.S. Department of Agriculture (September 2023) for AED equipment at headquarters; and recent smaller purchase orders for AED devices, electrodes, batteries, and CPR training aids from Naval Sea Systems Command, Defense Health Agency, Air Force Space Command, and the National Labor Relations Board.

Customer concentration is highly distributed across federal health and defense agencies. The top five customers by award count—Indian Health Service (18 awards), VA VISN 10 (16 awards), VA VISN 6 (13 awards), VA VISN 17 (10 awards), and Navy Bureau of Medicine and Surgery (9 awards)—account for only 23% of recent awards. By dollar value, the top five customers—VA VISN 20 ($6.7 million), VA VISN 6 ($1.8 million), VA VISN 21 ($615 thousand), VA VISN 22 ($529 thousand), and VA VISN 17 ($501 thousand)—represent 29% of combined potential value. The VA health system, across multiple Veteran Integrated Service Networks, is the dominant customer across both metrics.

Activity has been stable to declining: two awards in 2022, seven in 2023, eight in 2024, six in 2025, and three year-to-date in 2026. Only two awards valued at $3.2 million combined are scheduled to reach ultimate completion within the next twenty-four months, indicating minimal recompete exposure in the near term. The vendor carries 291 total awards (prime and sub) with $35.1 million in combined potential value and $17.9 million obligated (51% of potential). Subcontract activity is minimal (two sub-awards to date, both as an AED supplier to Fluor Marine Propulsion on Naval Nuclear Propulsion Program work awarded March 2026). The portfolio is dominated by individual purchase orders and delivery orders for AED equipment, replacement components (electrodes, batteries), and training aids, with no diversity beyond medical equipment and supplies procurement.